AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 9,031.85
+123.15 (1.38%)
At close: Dec 29, 2025
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 219.44 billion as of December 31, 2025. Its market cap has increased by 32.92% in one year.
Market Cap
219.44B
Enterprise Value
215.78B
Revenue
20.06B
Ranking
n/a
PE Ratio
110.15
Stock Price
9,031.85
Market Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 219.44B, an increase of 15,033.45%. That is a compound annual growth rate of 23.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 219.44B | -2.58% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 21.25T |
| HDFC Bank | 15.25T |
| Bharti Airtel | 12.66T |
| Tata Consultancy Services | 11.60T |
| ICICI Bank | 9.60T |
| State Bank of India | 9.07T |
| Infosys | 6.54T |
| Bajaj Finance | 6.13T |